![Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial - Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3402d8bd-b094-4f9e-a1fd-f6e857029ffa/gr1.gif)
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial -
![SciELO - Brasil - Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios SciELO - Brasil - Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios](https://minio.scielo.br/documentstore/1983-8034/fcxHwrCvndVNv4zRWS74WWt/cfa3675206f66e3f4c5be1f136f43a4a7cf885a2.jpg)
SciELO - Brasil - Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios Eticidade do uso de placebo em pesquisa clínica: proposta de algoritmos decisórios
![Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double- dummy, strategy trial - The Lancet Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double- dummy, strategy trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3f439d8a-803e-49d0-8e1b-dd029e4cf149/gr1_lrg.jpg)
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double- dummy, strategy trial - The Lancet
![PDF] Double-blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain | Semantic Scholar PDF] Double-blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/630532e31651ee387cdc428c2ecc4e924e2ad642/4-Figure1-1.png)
PDF] Double-blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain | Semantic Scholar
![Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo- controlled, phase 3 trial - The Lancet Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo- controlled, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e52a65a7-8607-4967-8701-3c310d11632e/gr1.jpg)
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo- controlled, phase 3 trial - The Lancet
![Techniques, Challenges and Strategies in Comparator Blinding | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services Techniques, Challenges and Strategies in Comparator Blinding | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services](https://media.pharmoutsourcing.com/m/30/article/178382-tab2.jpg)
Techniques, Challenges and Strategies in Comparator Blinding | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
![Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol ... Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol ...](https://bmjopen.bmj.com/content/bmjopen/7/9/e017121/F1.large.jpg)
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol ...
![Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis - Journal of the American Academy of Dermatology Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e896cbcd-514e-4b9d-bf69-d004e842dadb/gr1_lrg.gif)
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis - Journal of the American Academy of Dermatology
![Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double- dummy, phase 3 study - The Lancet Gastroenterology & Hepatology Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double- dummy, phase 3 study - The Lancet Gastroenterology & Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/27fdb44c-3631-4589-891e-2381152aa64d/gr1.gif)